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The Effect of Physician Endorsement on Patients’ Perceived Importance and Necessity in 
 Disclosing Genetic Disease to Family 
When a physician diagnoses a patient with a genetic disease, disclosure to family is an important 
communication action for both the patient and family. Timely disclosure by the patient to family may 
help to “activate” [1] family into providing needed support to the patient [2,3], as well as activate 
individuals in that family to be tested for the disease [4,5,6]. This study examines whether physician 
endorsement of disclosing a genetic disease diagnosis to family influences patients’ perceptions of 
importance and necessity to disclose to family their diagnosis. 
We conducted online surveys with patients (N = 237, Mean age: 54 years; 85.0% Caucasian) 
diagnosed with a genetic disease called polycystic kidney disease (PKD). The patients in this study are 
the first person in their family diagnosed with PKD, called the proband. Four variables were examined in 
this study. IVs included participant recall of physician explaining family members’ risk for the disease 
and recall of whether the physician suggested sharing the diagnosis with family. DVs were participant’s 
perceived importance and perceived necessity to disclose diagnosis to family, with each measured on a 
three-point scale.   
 Analyses revealed that participants were significantly more likely to think it was important to 
disclose when the physician explained that family members were at risk and to think it was important to 
disclose when the physician recommended disclosing the diagnosis to family. Based on these results, 
physicians should be made aware their endorsement of disclosing to family can significantly increase 
probands’ perceived importance and necessity of talking to their family and that emphasizing the 
genetic risk for family can increase a patient’s perception that it is important and necessary to tell their 
family. 
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